| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.1 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.1 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.1 |